Following groundbreaking work on a “speech neuroprosthesis” that enabled a paralyzed man to communicate using his brain signals, the lab team answered public questions about brain-computer interfaces and the limitations of translating brain signals into code.
We spoke to UCSF virologist Nadia Roan, PhD, about the latest developments in our knowledge of the Delta variant, including how the new variant spreads so efficiently, whether it causes more serious illness, and why she thinks vaccines will hold the line.
UCSF researchers developed a program that translates the hundreds of EEG traces into a 3-D movie showing activity in all recorded locations in the brain. The result is a multicolored 3-D heat map that looks very much like a meteorologist’s hurricane weather map.
UCSF researchers have leveraged two new molecules, one of which is currently in clinical oncology trials, to devise a dual-drug therapy for alcohol use disorder (AUD), without the side effects or complications associated with current treatment regimens.
UCSF and The Atlantic have announced that the crowdsourced digital archive documenting the face of the pandemic in the United States will become part of the University’s permanent library collection and is accessible to researchers and the public.
UCSF researchers in collaboration with the Centers for Disease Control’s Tuberculosis Trials Consortium and the AIDS Clinical Trials Group published a landmark study that demonstrated a new four-month treatment regimen for tuberculosis was safe and as efficacious as the standard six-month therapy.
Scientists at UCSF and Makerere University in Kampala, Uganda have developed an intervention that makes use of a portable laboratory testing technology to help HIV providers order, process, and receive HIV viral load results quickly, and shorten the time it takes for patients to get their results.